Avascular Necrosis (AVN) Long-Term Follow-up

NCT ID: NCT00833430

Last Updated: 2016-02-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

35 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-06-30

Study Completion Date

2013-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Long-term follow-up of IDE patients for publication

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This device (Hedrocel AVN Intervention Implant) was approved via 510(k) on April 15, 2005. One site was left open to follow patients to 5 year follow-up for publication of device survivorship.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Avascular Necrosis Femoral Head Collapse

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient qualifies for core decompression based on physical exam
* No history of core decompression
* Patient is willing and able to provide written informed consent

Exclusion Criteria

* Patient has been diagnosed as Stage 0, III, IV, V or VI using the Steinberg/UPenn staging system.
* Patient's BMI is \>40
* Patient is mentally compromised
* Patient has neurological condition in ipsilateral or contralateral limb, which affect lower limb function
* The patient has had a proximal femoral osteotomy or internal fixation in the affected hip.
* The patient has undergone previous treatment for AVN
* Previous hip conditions
* Patient's bone stock is insufficient
* Patient has diagnosed systemic disease
* Patient is a pregnant female
* Patient is unable or unwilling to attend postop follow-up visits
* Patient has received investigational drug within the previous 6 months or an investigational device within the last 12 months
* Patient has an active or latent infection
* Patient has metal sensitivity
* Patient is a prisoner
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zimmer Biomet

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Emory Orthopedic Clinic

Atlanta, Georgia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IC006-99

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.